Manandhar, Nora Ranjitkar, Gyan Krishna Kayashta, and Paras Kumar Acharya. 2018. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences 5 (1):47-56. https://doi.org/10.3126/jpahs.v5i1.24042.